| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.64 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |